Physician profile
Jia Guo
NPI 1386105773
$1,900.00
in general payments reported to CMS, 2019-2025
16 companies · $680 in 2025
The $680 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.34 · 2022: $305 · 2023: $557 · 2024: $333 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $533.66 | 2023-2025 | Pascal, Sapien 3 Ultra Resilia |
| Pfizer INC. | $202.56 | 2023-2025 | |
| Cleerly, INC. | $170.42 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Philips North America LLC | $162.95 | 2022-2024 | (P88) Igt Devices Fm |
| Astrazeneca Pharmaceuticals LP | $147.74 | 2022-2023 | Brilinta |
| Terumo Medical Corporation | $141.46 | 2022-2023 | Glidesheath Slender, Navicross, Glidewire |
| Abbott Laboratories | $135.94 | 2024-2025 | Amplatzer, Cardiomems, Amplatzer Amulet |
| Abiomed | $69.45 | 2024 | Impella |
| Lantheus Medical Imaging, INC. | $57.33 | 2023 | Definity |
| E.R. Squibb & Sons, L.L.C. | $52.78 | 2023-2024 | Camzyos |
| Novartis Pharmaceuticals Corporation | $50.19 | 2024 | |
| Janssen Pharmaceuticals, INC | $44.18 | 2022-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $43.52 | 2022-2023 | Verquvo |
| Heartflow, INC. | $32.73 | 2022-2024 | |
| Boston Scientific Corporation | $29.75 | 2024 | Watchman Flx |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $25.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jia Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.